Markets:

Overview

News

Currencies

International

Treasuries

Virpax Pharmaceuticals, Inc. - Common Stock (NQ:VRPX)

0.6695 UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 3, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Virpax Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

What's going on in today's after hours session ↗

April 04, 2025

The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

What's going on in today's after hours session ↗

April 03, 2025

Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 03, 2025

Via Benzinga

What's going on in today's session ↗

April 03, 2025

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

Via Chartmill

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

April 03, 2025

Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

11 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 03, 2025

Via Benzinga

Top movers in Wednesday's session ↗

April 02, 2025

Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.

Via Chartmill

Top stock movements in today's session. ↗

March 21, 2025

Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Here are the top movers in Friday's session. ↗

March 21, 2025

Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Which stocks are gapping on Friday? ↗

March 21, 2025

Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

Discover the top movers in Friday's pre-market session. ↗

March 21, 2025

As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Why Five Below Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗

March 20, 2025

Via Benzinga

US Stocks Likely To Open Higher As Fed Says Tariff-Induced Inflation Will Be 'Transitory:' Any Pullback In Equities 'Offers An Opportunity,' Says Expert ↗

March 20, 2025

U.S. stock futures rose on Thursday following the Federal Open Market Committee's decision on Wednesday calling inflation 'transitory'.

Via Benzinga

Topics Economy

Stay updated with the stocks that are on the move in today's after-hours session. ↗

March 19, 2025

After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

Via Chartmill

These stocks are the most active in today's session ↗

March 19, 2025

These stocks are making the most noise in today's session. Stay tuned for the latest updates!

Via Chartmill

Virpax Pharmaceuticals Announces Reverse Stock Split

March 19, 2025

From Virpax Pharmaceuticals, Inc.

Via Business Wire

Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket ↗

March 19, 2025

Via Benzinga

Which stocks are moving after the closing bell on Tuesday? ↗

March 18, 2025

Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 18, 2025

Via Benzinga

Virpax Receives Positive Probudur™ Results for Dose Range Study Moves Towards Next Steps in IND

March 18, 2025

From Virpax Pharmaceuticals, Inc.

Via Business Wire

What's going on in today's session ↗

March 18, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 18, 2025

Via Benzinga

Traders are paying attention to the gapping stocks in Tuesday's session. ↗

March 18, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.

Via Chartmill

Discover the top movers in Tuesday's pre-market session. ↗

March 18, 2025

Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 18, 2025

Via Benzinga

Why Harrow Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket ↗

March 18, 2025

Via Benzinga

Top movers in Monday's after hours session ↗

March 17, 2025

As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 17, 2025

Via Benzinga

Virpax Looking to Use MET to Develop Intranasal COVID Vaccine

March 07, 2025

From Virpax Pharmaceuticals, Inc.

Via Business Wire

Virpax’s NES100 to be Presented at The Society of Toxicology by NCATS

March 05, 2025

From Virpax Pharmaceuticals, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.